search
drug discovery
Trends
- 1Roche outlines plans for autonomous AI laboratories●Roche outlines plans to move towards autonomous AI labs
Roche has outlined plans to move towards autonomous AI laboratories, according to a Reuters report. The Swiss pharmaceutical company intends to use artificial intelligence to run elements of its research operations with reduced human involvement, a step that would put it among the first major drugmakers to pursue fully automated, AI-driven labs.
- 2OpenAI leads $150M funding round for drug revival startup Biossil▼OpenAI leads $150M round for drug-reviving startup Biossil
OpenAI has led a $150 million investment round in Biossil, a startup focused on reviving abandoned drugs. The company specializes in taking discontinued or shelved pharmaceutical compounds and finding new paths to develop them. It is a notable move for OpenAI's investment arm, signaling growing interest in applying AI to drug discovery and development, and fresh attention on the drug-repurposing sector.